Inhalimed
Next Generation of High Precision Nebuizers
Health Tech & Life Sciences
Stealth Mode
Company Overview
Snapshot
Founded in July 2024, Inhalimed operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of next-generation high-precision nebulizers.
Business overview
Inhalimed is developing advanced inhalation delivery solutions for the pharmaceutical and wellness industries. The company's core technology centers on next-generation high-precision nebulizers, aiming to enhance the efficacy and precision of drug delivery. Inhalimed operates within the Health Tech & Life Sciences sector, specifically targeting the Pharma & Medical Biotechnology and Drug Delivery markets.
Log in to access full profile ›Company Intelligence Q&A
- When was Inhalimed founded?
- Inhalimed was founded in July 2024.
- What is Inhalimed's primary focus?
- Inhalimed focuses on the future of inhalation delivery for pharma and wellness, developing next-generation high-precision nebulizers.
- What sector does Inhalimed operate in?
- Inhalimed operates within the Health Tech & Life Sciences sector, with a specific focus on Pharma & Medical Biotechnology and Drug Delivery.
- What is the current employee size of Inhalimed?
- Inhalimed currently has 1–10 employees.
- What is Inhalimed's current funding stage?
- Inhalimed is currently in the Pre-Funding stage, having not yet disclosed any funding rounds or investors.